SCHEMBL1128490

SCHEMBL1128490

CC(C)(O)CCn1c2ccccc2c2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 3/20 0.50
FABP5 Q01469 3/20 0.50
FABP3 P05413 1/20 0.50
KDM4E B2RXH2 2/20 0.49
CYP1A2 P05177 1/20 0.48
CYP2C19 P33261 1/20 0.48
HDAC6 Q9UBN7 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
BACE1 P56817 2/20 0.46
GPR3 P46089 1/20 0.45
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
HDAC1 Q13547 1/20 0.42
MAOA P21397 1/20 0.42
ACHE P22303 1/20 0.42
MAOB P27338 1/20 0.42
GRIN1 Q05586 1/20 0.42
GRIN2A Q12879 1/20 0.42
GRIN2B Q13224 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1128289 0.85 KDM4E (0.60) FABP4FABP5FABP3KDM4EMEN1
SCHEMBL1128298 0.81 MAPT (0.70) MEN1KMT2AALDH1A1SIGMAR1
SCHEMBL1128885 0.80 CYP1A2 (0.52) FABP4FABP5FABP3KDM4ECYP1A2
SCHEMBL21426092 0.79 CYP1A2 (0.47) FABP4FABP5FABP3KDM4ECYP1A2
SCHEMBL30745333 0.79 CNR2 (0.56) CYP1A2ALDH1A1CNR1CNR2
SCHEMBL18014692 0.77 FABP4 (0.51) FABP4FABP5CYP1A2CYP2C19MEN1
SCHEMBL9768532 0.76 CYP1A2 (0.70) FABP4FABP5FABP3KDM4ECYP1A2
SCHEMBL30904706 0.75 CNR1 (0.53) CYP1A2MEN1KMT2AALDH1A1CNR1
SCHEMBL31357282 0.74 CNR2 (0.52) ALDH1A1CNR1CNR2
SCHEMBL22298166 0.73 PGR (0.49) FABP4FABP5MAOAACHEMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10005730-B2 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2018-06-26 US disclosed
US-20160102056-A1 3-AMINOCARBAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PREPARATION METHOD THEREFOR AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2016-04-14 US disclosed
US-9249097-B2 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2016-02-02 US disclosed
US-20140107174-A1 3-AMINOCARBAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PREPARATION METHOD THEREFOR AZIENDE CHIM. RIUN. ANG. FRANC. AC.R.A.F. S.p.A. (IT) 2014-04-17 US disclosed
US-8637682-B2 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2014-01-28 US disclosed
EP-2282994-B1 3-AMINOCARBAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PREPARATION METHOD THEREFOR ACRAF (IT) 2013-07-03 EP disclosed
US-20110060025-A1 3-AMINOCARBAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PREPARATION METHOD THEREFOR AZIENDE CHIM. RIUN.ANG.FRANC. A.C.R.A.F S.p.A. (IT) 2011-03-10 US disclosed
EP-2282994-A1 3-AMINOCARBAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PREPARATION METHOD THEREFOR Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. (IT) 2011-02-16 EP disclosed
WO-2009138376-A1 3-AMINOCARBAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PREPARATION METHOD THEREFOR AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2009-11-19 WO disclosed
EP-2119705-A1 3-Aminocarbozole compound, pharmaceutical composition containing it and preparation method therefor AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. (IT) 2009-11-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10005730-B2 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor PTGES3, PTGER3, PTGES FABP4 475/4885FABP5 803/4885FABP3 448/4885
US-20160102056-A1 3-AMINOCARBAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PREPARATION METHOD THEREFOR PTGES3, PTGER3, PTGES FABP4 475/4885FABP5 803/4885FABP3 448/4885
US-20140107174-A1 3-AMINOCARBAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PREPARATION METHOD THEREFOR PTGES3, PTGER3, PTGES FABP4 475/4885FABP5 803/4885FABP3 448/4885
US-20110060025-A1 3-AMINOCARBAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PREPARATION METHOD THEREFOR PTGES3, PTGER3, PTGES FABP4 475/4885FABP5 803/4885FABP3 448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.